Tenet Healthcare (NYSE:THC) Announces Earnings Results

Tenet Healthcare (NYSE:THC) released its quarterly earnings results on Tuesday. The company reported $3.22 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $1.77, Briefing.com reports. Tenet Healthcare had a return on equity of 26.76% and a net margin of 12.53%. The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.15 billion. During the same quarter in the prior year, the company posted $1.42 EPS. Tenet Healthcare’s quarterly revenue was up 6.9% compared to the same quarter last year.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $118.96 on Friday. Tenet Healthcare has a one year low of $51.04 and a one year high of $120.03. The stock’s fifty day moving average is $99.29 and its 200 day moving average is $81.68. The stock has a market cap of $11.62 billion, a P/E ratio of 4.62, a P/E/G ratio of 2.63 and a beta of 2.09. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.42 and a current ratio of 1.44.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 17,000 shares of the firm’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $94.84, for a total transaction of $1,612,280.00. Following the sale, the executive vice president now directly owns 8,148 shares of the company’s stock, valued at $772,756.32. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Tenet Healthcare news, EVP Thomas W. Arnst sold 17,000 shares of the firm’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $94.84, for a total transaction of $1,612,280.00. Following the sale, the executive vice president now directly owns 8,148 shares of the company’s stock, valued at $772,756.32. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Richard J. Mark sold 14,000 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $98.98, for a total value of $1,385,720.00. Following the transaction, the director now owns 33,303 shares of the company’s stock, valued at approximately $3,296,330.94. The disclosure for this sale can be found here. Insiders have sold a total of 51,268 shares of company stock valued at $4,944,810 over the last ninety days. 0.93% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

THC has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft upped their target price on Tenet Healthcare from $100.00 to $126.00 and gave the stock a “buy” rating in a report on Friday, April 12th. UBS Group upped their price target on Tenet Healthcare from $137.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday. Royal Bank of Canada upped their price target on Tenet Healthcare from $109.00 to $136.00 and gave the stock an “outperform” rating in a research note on Wednesday. Wolfe Research upgraded Tenet Healthcare from a “peer perform” rating to an “outperform” rating and set a $122.00 price target on the stock in a research note on Wednesday, March 27th. Finally, Mizuho reiterated a “buy” rating and set a $130.00 target price (up from $118.00) on shares of Tenet Healthcare in a research note on Wednesday. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $113.19.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.